Drug Profile
Ethinylestradiol/levonorgestrel + ethinylestradiol - Teva Pharmaceuticals Industries/Theramex
Alternative Names: DP3; DR-103; DR-105; LoSeasonique; SeasoniqueLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Duramed Pharmaceuticals Inc
- Developer Duramed Pharmaceuticals Inc; Endo International; Teva Pharmaceutical Industries; Theramex
- Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
- Discontinued Menstrual migraine
Most Recent Events
- 05 Feb 2019 Chemical structure information added
- 01 Feb 2018 Teva Women's Health was sold by Teva Pharmaceuticals to CVC Capital Partners, to create an international pharmaceutical company dedicated to Women’s Health named Theramex
- 14 Apr 2014 Registered as Seasonique® for Pregnancy (Prevention) in Brazil (PO)